ICER releases draft evidence report on treatment for non-cystic fibrosis bronchiectasis

ICER

23 July 2025 - Public comment period now open until 19 August 2025; requests to make oral comment during public meeting also being accepted.

The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of brensocatib (Insmed) for non-cystic fibrosis bronchiectasis.

Read ICER Announcement

Michael Wonder

Posted by:

Michael Wonder